We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Countdown to Doximity (DOCS) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Read MoreHide Full Article
Wall Street analysts forecast that Doximity (DOCS - Free Report) will report quarterly earnings of $0.24 per share in its upcoming release, pointing to a year-over-year increase of 9.1%. It is anticipated that revenues will amount to $127.46 million, exhibiting an increase of 10.6% compared to the year-ago quarter.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
With that in mind, let's delve into the average projections of some Doximity metrics that are commonly tracked and projected by analysts on Wall Street.
Analysts' assessment points toward 'Revenues- Other' reaching $7.54 million. The estimate indicates a year-over-year change of -2.8%.
Analysts forecast 'Revenues- Subscription' to reach $119.99 million. The estimate suggests a change of +11.6% year over year.
Analysts expect 'Number of customers with at least $100,000 of revenue' to come in at 294. Compared to the present estimate, the company reported 290 in the same quarter last year.
Over the past month, Doximity shares have recorded returns of -3.6% versus the Zacks S&P 500 composite's +5.3% change. Based on its Zacks Rank #4 (Sell), DOCS will likely underperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Countdown to Doximity (DOCS) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Wall Street analysts forecast that Doximity (DOCS - Free Report) will report quarterly earnings of $0.24 per share in its upcoming release, pointing to a year-over-year increase of 9.1%. It is anticipated that revenues will amount to $127.46 million, exhibiting an increase of 10.6% compared to the year-ago quarter.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
With that in mind, let's delve into the average projections of some Doximity metrics that are commonly tracked and projected by analysts on Wall Street.
Analysts' assessment points toward 'Revenues- Other' reaching $7.54 million. The estimate indicates a year-over-year change of -2.8%.
Analysts forecast 'Revenues- Subscription' to reach $119.99 million. The estimate suggests a change of +11.6% year over year.
Analysts expect 'Number of customers with at least $100,000 of revenue' to come in at 294. Compared to the present estimate, the company reported 290 in the same quarter last year.
View all Key Company Metrics for Doximity here>>>
Over the past month, Doximity shares have recorded returns of -3.6% versus the Zacks S&P 500 composite's +5.3% change. Based on its Zacks Rank #4 (Sell), DOCS will likely underperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>